Macquarie upgraded Core Scientific to outperform from neutral and hiked its price target on the stock to $34 after the collapse of the CoreWeave merger. The deal failing was seen as a positive outcome ...
Original Image Link
Source:www.coindesk.com
Original Image Link
Source:www.coindesk.com
Posted: 2025-10-31 07:37:00










